Your browser doesn't support javascript.
loading
Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights.
Shokoohian, Bahare; Negahdari, Babak; Aboulkheyr Es, Hamidreza; Abedi-Valugerdi, Manuchehr; Baghaei, Kaveh; Agarwal, Tarun; Maiti, Tapas Kumar; Hassan, Moustapha; Najimi, Mustapha; Vosough, Massoud.
Afiliação
  • Shokoohian B; Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Negahdari B; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Aboulkheyr Es H; Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Abedi-Valugerdi M; School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia.
  • Baghaei K; Laboratory Medicine, Karolinska Institutet, Experimental Cancer Medicine, Clinical Research Center (KFC), Novum, Karolinska University Hospital-Huddinge and Biomolecular and Cellular Medicine (BCM, Stockholm, Sweden.
  • Agarwal T; Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Maiti TK; Department of Biotechnology, Indian Institute of Technology, Kharagpur, India.
  • Hassan M; Department of Biotechnology, Indian Institute of Technology, Kharagpur, India.
  • Najimi M; Laboratory Medicine, Karolinska Institutet, Experimental Cancer Medicine, Clinical Research Center (KFC), Novum, Karolinska University Hospital-Huddinge and Biomolecular and Cellular Medicine (BCM, Stockholm, Sweden.
  • Vosough M; Laboratory of Pediatric Hepatology and Cell Therapy, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium.
J Cell Mol Med ; 25(18): 8602-8614, 2021 09.
Article em En | MEDLINE | ID: mdl-34423899

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Combinada / Carcinoma Hepatocelular / Terapia de Alvo Molecular / Imunoterapia / Neoplasias Hepáticas Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Combinada / Carcinoma Hepatocelular / Terapia de Alvo Molecular / Imunoterapia / Neoplasias Hepáticas Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article